Evidence map›Paper›PMID 40601767›Full record

ArticlePloS one2025

Development and validation of a nomogram for predicting false negative IGRA results in pulmonary tuberculosis patients using propensity score matching.

Feng Zhang, Yong Gao, Tuantuan Li, Wei Zhang

Abstract readValidation Study
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Feng ZhangNo.2 People's Hospital of Fuyang City, Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang, Anhui, China.
Yong GaoNo.2 People's Hospital of Fuyang City, Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang, Anhui, China.
Tuantuan LiNo.2 People's Hospital of Fuyang City, Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang, Anhui, China.
Wei ZhangNo.2 People's Hospital of Fuyang City, Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang, Anhui, China.ORCID https://orcid.org/0009-0009-2508-8428

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aims to explore factors influencing false-negative results in Interferon-Gamma Release Assay (IGRA) for patients with Pulmonary Tuberculosis (PTB), and develop a nomogram model to predict IGRA false negatives, thereby optimizing clinical diagnosis and treatment decisions.

methodsData were collected from January 2023 to September 2024 at the Second People's Hospital of Fuyang City, involving 143 PTB patients. Among them, 63 patients who were IGRA negative but pathogen positive formed the observation group, while 80 patients who were both IGRA and pathogen positive constituted the control group. Propensity Score Matching (PSM) was used to balance potential confounding factors between the two groups. Clinical characteristics and laboratory indicators were compared, followed by logistic regression analysis to identify independent risk factors affecting IGRA results. A nomogram model was constructed based on these factors and its predictive performance evaluated.

resultsAfter PSM, each group consisted of 55 patients. The observation group showed significantly lower levels of white blood cell count (WBC), neutrophil count (NEUT), lymphocyte count (LYM), red blood cell count (RBC), hemoglobin (HGB), and albumin (ALB) compared to the control group (P < 0.05). Multivariate analysis ultimately identified RBC, ALB and NLR as independent predictors of IGRA false-negativity. The developed nomogram model demonstrated good calibration (χ² = 4.482, P = 0.811), with an area under the receiver operating characteristic curve (AUC) of 0.764 (95% CI: 0.675-0.853). Decision curve analysis indicated that the net benefit of predicting false-negative IGRA results using this nomogram model was greater than 0 when the threshold probability ranged from 0.15 to 0.95.

conclusionDecreased RBC/ALB and elevated NLR may be pivotal factors contributing to false-negative IGRA results in PTB patients. The three-variable nomogram shows enhanced predictive performance, serving as a quantitative tool to identify high-risk cases, particularly for patients with malnutrition or pronounced inflammatory status.

Indexed as

Interferon-gamma Release TestsNomogramsTuberculosis, PulmonaryAdultAgedFalse Negative ReactionsFemaleHumansMaleMiddle AgedPropensity ScoreRetrospective StudiesRisk FactorsROC Curve

Identifiers

PMID40601767
PMCPMC12220989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.